We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Biogen Idec Gets 483 for Overlooking Particles
Biogen Idec Gets 483 for Overlooking Particles
July 1, 2013
The FDA handed Biogen Idec’s Cambridge, Mass. facility a Form 483 after the company released a drug substance destined for compounding that contained white particles.